Chromium Picolinate for the Treatment of Metabolic Syndrome
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether chromium supplements can reduce symptoms of
metabolic syndrome, a collection of symptoms that increase one's risk for developing heart
disease, stroke, and diabetes.
Phase:
N/A
Details
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)